‘Serious’ polarization of R&D investment among innovative pharmaceutical companies
It was criticized polarization of R&D investments was getting intensified among innovative pharmaceutical companies certified to have excellent new drug development and overseas expansion capabilities.
While there is a company spending more money into R&D than sales they make, there were compani...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.